Ocugen Announces Positive Clinical Study Update from the Pha

FavorablesafetyandtolerabilityprofileofOCU400investigationaldrugproductin RP and LCA subjects to dateClinical study update suggests continued positive trends in Best-Corrected Visual Acuity (BCVA) and Multi-Luminance Mobility Testing (MLMT), as well as positive trends in Low-Luminance

Related Keywords

Los Angeles , California , United States , Tarun Upadhyay , Lejla Vajzovic , David Boyer , Shankar Musunuri , Head Of Research , Ocugen Inc , Retina Vitreous Associates Medical Group , Linkedin , Head Of Communications , Twitter , Keck School Of Medicine Los Angeles , Retina Foundation Of The , Duke University School Of Medicine , Best Corrected Visual Acuity , Multi Luminance Mobility Testing , Low Luminance Visual Acuity , Retinitis Pigmentosa , Chief Executive Officer , Chief Scientific Officer , Associate Professor , Duke Vitreoretinal Fellowship Program , Duke Eye Center , Duke University School , David Birch , Scientific Director , Retina Foundation , Clinical Professor , Keck School , Medicine Los Angeles , Retina Vitreous Associates Medical , Region ,